On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

C19orf12

chromosome 19 open reading frame 12

The C19orf12 gene provides instructions for a protein thought to be involved in maintaining lipid balance within mitochondria, and is associated with neurodegenerative conditions such as MPAN. The C19orf12 gene encodes a protein found within the mitochondrial membrane, where it is believed to contribute to lipid homeostasis.

Chromosome 19q12 Various HGNC:25443 Tier C
C19orf12 19q12 p arm q arm 19

C19orf12 is located on the long (q) arm of chromosome 19, at band 19q12. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 19 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The C19orf12 gene, or chromosome 19 open reading frame 12, is located on chromosome 19. It provides the genetic blueprint for a protein whose precise function is still under investigation, but it is thought to play a role in maintaining cellular health. This gene is primarily associated with neurodegenerative disorders, particularly those affecting movement and brain function.

What the gene does

The C19orf12 gene produces a protein localised to the membrane of mitochondria, which are vital cellular organelles responsible for energy production. While its exact role is not fully understood, research suggests the C19orf12 protein contributes to lipid homeostasis, the process of maintaining a stable balance of fats within the cell. This function is crucial for proper mitochondrial activity and overall cellular metabolism.

Video: Genetics 101

Chromosome location

The C19orf12 gene is situated on the long (q) arm of chromosome 19 at position 12, designated as 19q12. It contains several exons, which are the protein-coding regions of the gene. The gene codes for a protein consisting of 141 amino acids.

Protein structure

The C19orf12 protein is composed of 141 amino acids. Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Variants in the C19orf12 gene can lead to altered protein function or expression. These genetic changes can range from single base pair substitutions to larger deletions or insertions within the gene. Such variants are often inherited in an autosomal recessive pattern.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for C19orf12.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.164_166delGGG
Deletion
- Pathogenic/Likely pathogenic ★★☆☆ C19ORF12-related disorders
c.161G>A
single nucleotide variant
p.Gly54Glu Pathogenic/Likely pathogenic ★★☆☆ Hereditary spastic paraplegia 43
c.166del
Deletion
- Pathogenic/Likely pathogenic ★★☆☆ Hereditary spastic paraplegia 43
c.171_181del
Deletion
p.Gly58fs Pathogenic/Likely pathogenic ★★☆☆ Autosomal dominant C19orf12-related disorders
c.172G>A
single nucleotide variant
p.Gly58Arg Pathogenic/Likely pathogenic ★★☆☆ Hereditary spastic paraplegia 43
c.205C>T
single nucleotide variant
p.Gln69Ter Pathogenic/Likely pathogenic ★★☆☆ Neurodegeneration with brain iron accumulation 4
c.215C>T
single nucleotide variant
p.Pro72Leu Pathogenic/Likely pathogenic ★★☆☆ C19ORF12-related disorders
c.245del
Deletion
p.Pro82fs Pathogenic/Likely pathogenic ★★☆☆ Neurodegeneration with brain iron accumulation 4
c.-2C>T
single nucleotide variant
T11M Pathogenic/Likely pathogenic ★★☆☆ C19ORF12-related disorders
c.371dup
Duplication
p.Met124fs Pathogenic/Likely pathogenic ★★☆☆ Neurodegeneration with brain iron accumulation 4

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the C19orf12 gene are primarily associated with mitochondrial membrane protein-associated neurodegeneration (MPAN). This condition is characterised by progressive neurological symptoms, including movement disorders and cognitive decline, often accompanied by iron accumulation in specific brain regions. The gene has also been implicated in other neurodegenerative disorders.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

The C19orf12 gene is included in several NHS Genomic Medicine Service (GMS) approved panels, indicating its clinical relevance for genetic testing in the UK. These panels cover conditions such as 'Dystonia, chorea or related movement disorder, adult onset' and 'Hereditary spastic paraplegia'. It is also part of panels for 'Likely inborn error of metabolism' and 'Neurodegenerative disorders, adult onset', among others.

Frequently asked questions

What is mitochondrial membrane protein-associated neurodegeneration (MPAN)?

MPAN is a progressive neurodegenerative disorder caused by variants in the C19orf12 gene. It is characterised by movement problems, neurological issues that worsen over time, and an unusual accumulation of iron in certain parts of the brain.

How is C19orf12 gene variation inherited?

Variants in the C19orf12 gene are typically inherited in an autosomal recessive manner. This means an individual must inherit two copies of the altered gene, one from each parent, to develop the associated condition.

What is the function of the C19orf12 protein?

The C19orf12 protein is found in the membrane of mitochondria and is thought to play a role in lipid homeostasis, which is the process of maintaining a balanced level of fats within cells. Its precise mechanisms are still being investigated.

References

  1. Kruer MC, Salih MA, Mooney C. C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene. 2014. PMID: 24361204
  2. Dogu O, Krebs CE, Kaleagasi H. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clinical genetics. 2013. PMID: 23278385
  3. Landouré G, Zhu PP, Lourenço CM. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Human mutation. 2013. PMID: 23857908
  4. Deschauer M, Gaul C, Behrmann C. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. Journal of neurology. 2012. PMID: 22584950
  5. Hartig MB, Iuso A, Haack T. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. American journal of human genetics. 2011. PMID: 21981780
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .